Email address
[email protected]Contact number
02074051111Share profile
Band 4
Provided by Thomas Lunt
Thomas’ practice encompasses all areas in intellectual property including patents and SPCs, trade marks, passing off, copyright, and confidential information.
His recent patent cases from the life sciences field include Akebia v Fibrogen (a leading case on the approach to sufficiency of functional claims) and Sandoz, Teva v BMS (the first appellate decision on plausibility following G2/21) and, for tech and telecoms, matters include AutoStore Technology v Ocado Group and R2 v Intel. He acted in the Dr Reddy’s, NHS England v Warner-Lambert damages inquiry concerning pregabalin (which was listed on The Lawyer’s “Top 20 Cases of 2023”) and is presently instructed in the Panasonic v Xiaomi and Lenovo v Ericsson FRAND proceedings. He is a contributing author to Terrell on the Law of Patents, editing the chapters on construction and plausibility.
Thomas maintains an active trade marks practice and has worked on cases across diverse sectors including beverages, luxury personal goods, and medical devices. In addition to his experience before the High Court, he represents clients unled before the UK IPO.
2019-2020: 12-month pupillage at Three New Square to Miles Copeland, Jeremy Heald, Joe Delaney, Stuart Baran and Geoff Pritchard.
2017-2018: BPTC at BPP Birmingham: Outstanding; 1st in cohort.
2016-2017: GDL at BPP Birmingham: Distinction. 2012-2016: MChem Chemistry at Lincoln College, Oxford: 1st class. Part-II thesis in soft chemistry of solid- state crystalline compounds from the cerium oxychalcogenide series.
Provided by Chambers
Thomas Lunt is praised for his commitment to his work, technical skills and collaborative nature. He represents clients in life science and technology focused patent litigation. He appears in complex matters for notable clients in the life sciences space.
Provided by Chambers
Thomas is super clever and super hard-working. He is one to watch.
One of the best up-and-coming junior barristers in pharma patent litigation. Thomas is extremely hard-working and his work output is excellent.
He is a rising star among junior barristers for complex pharmaceutical patent litigation cases. He works extremely hard and delivers excellent written work product that is clear and commercial.
Thomas is very experienced, and his work and thinking punches far beyond his years of call.
Thomas is super clever and super hard-working. He is one to watch.
One of the best up-and-coming junior barristers in pharma patent litigation. Thomas is extremely hard-working and his work output is excellent.
He is a rising star among junior barristers for complex pharmaceutical patent litigation cases. He works extremely hard and delivers excellent written work product that is clear and commercial.
Thomas is very experienced, and his work and thinking punches far beyond his years of call.
